IPF Treatment Trial

HR Show

PORTSMOUTH, Va. (WAVY) – Idiopathic pulmonary fibrosis, or IPF, is the most common type of fibrosis. It is a disease that causes scarring of the lungs. Tidewater Physicians Multispecialty Group (TPMG) is conducting a clinical research trial on IPF and they need your help. Dr. Vijay Subramaniam joined us with the details of the trial.

TPMG’s IPF Investigational Treatment Trial
To learn more about TPMG’s IPF Investigational Treatment Trial, get in touch with Dr. Subramaniam and his team at (757) 741-0981 or by email.
You can also visit Clinicaltrial.net.

This segment of The Hampton Roads Show is sponsored by TPMG.


MORE FROM HRS!

Copyright 2020 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

HRS Contests

HRS Contests



Be On The Hampton Roads Show

Be On The Hampton Roads Show


We love featuring the people of Hampton Roads on the show and providing an opportunity for organizations and businesses to inform the community.  Click here for details.


HR Show on FB

HR Show on Twitter

Trending Stories

Don't Miss

***Don’t Miss Module Removal CSS***